SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " ml " 4,875 found 🔀 AI-powered Shuffle
Dodgers vs Cubs Highlights ⚾️ MLB on FOX
Check out the best highlights between the Los Angeles Dodgers and the Chicago Cubs.
Etsy laying off 12% of staff in bid to streamline business, position for growth
Etsy announced the layoffs along with second-quarter earnings.
Sanofi suspends chronic lung disease phase 2 study, tied to ‘strategic business reasons’
Sanofi halted a phase 2 trial testing a monoclonal antibody, SAR445399, in non-cystic fibrosis bronchiectasis, Fierce Biotech has learned. The trial, which began only back in April, was a randomized, double-blind, placebo-controlled study to measure the reduction in mucus plug score following treatment with SAR445399 compared with placebo in adults aged 18 to 80 years with NCFB, a chronic lung disease. The trial was officially reported as halted on July 29, the day before Sanofi’s second-quarter earnings call. The decision to pause the trial was made “as part of a company-wide portfolio review for strategic business reasons,” and not due to safety concerns, a Sanofi spokesperson told Fierce. The move to pause the NCFB trial comes during a trying time for Sanofi following a year filled with a series of trial fails. In February, the French pharma ousted CEO Paul Hudson and appointed Merck KGaA leader Belén Garijo, M.D., Ph.D., to steer the ship. Since then, Garijo has been doing a deep dive on correcting the company’s strewn R&D and clinical strategies. On July 24, Sanofi scrapped amlitelimab for atopic dermatitis, despite its lore as being a potential $5 billion blockbuster. During its second-quarter report, the company abandoned two more assets, balinatunfib and itepekimab, following failed trial results in psoriasis and chronic obstructive pulmonary disease, respectively. SAR445399, only first revealed by Sanofi in 2023, is an anti-interleukin-1 receptor 3 monoclonal antibody developed to block the interleukin 1, 33, and 36 cytokine pathways. These pathways can be important in chronic immune-related dermatologic diseases, such as atopic dermatitis and hidradenitis suppurativa, as well as respiratory conditions, such as NCFB. Related Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues NCFB affects roughly half a million people in the U.S., with a global incidence of greater than one million cases. In August 2025, Insmed received FDA approval for Brinsupri, a DPP1 inhibitor targeting neutrophil activation, for treatment of NCFB in adults and kids ages 12 and older. The British biotech Infex Therapeutics showed promising NCFB phase 2a data using their monoclonal antibody, INFEX702, which acts by disabling Pseudomonas aeruginosa, a bacteria known to be a major pathogen of NCFB. Sanofi is currently running a separate phase 2 study testing SAR445399 as a potential treatment for the inflammatory skin condition hidradenitis suppurativa.
Dodgers vs Cubs Highlights ⚾️ MLB on FOX
Check out the best highlights between the Los Angeles Dodgers and the Chicago Cubs.
Former Lions WR, Pro Bowler reportedly lands with 49ers
KhaDarel Hodge, who spent the 2021 season in Detroit, is headed to San Francisco after earning Pro Bowl honors as a special teamer with Atlanta.
HotSchedules streamlines restaurant workforce management tools
Restaurants benefit from HotSchedules' AI-driven platform, simplifying labor management, reducing errors, and enhancing employee satisfaction.
Cyclosporiasis Cases in Michigan Climb to Over 12,000, State Health Officials Say
Aug 5 (Reuters) - Michigan health officials reported 12,218 cases linked to an outbreak of cyclosporiasis on Wednesday, an increase of 710 cases since its last update a day earlier. Michigan has reported the first two deaths associated with the outbreak, saying both individuals had significant ...
See detailed plasma whirlpools in new video of the sun’s surface
Video published in a study Wednesday supports a theory of what happens on the sun’s surface.
This OnlyFans competitor, developed at Harvard, wants to rethink the adult entertainment industry
MintStars, an adult platform with paid subscribers and a streamlined payment system for content creators, was incubated at Harvard Innovation Labs in Boston in 2023.
Complete Health to pay $14M to settle Medicare Advantage fraud allegations
The value-based primary care provider submitted false diagnosis codes to the CMS for three years, inflating its reimbursement by millions of dollars, according to the DOJ.
MLB games today: Schedule, times, how to watch for Aug. 5
Here's the full MLB schedule, for Aug. 5, including game times, TV channels, scores and how to stream.
Malay nationalism surge threatens to end Malaysia’s reform experiment
Since becoming prime minister in 2022, Anwar has struggled to win over support from Malaysia’s Malay-Muslim majority.
Small Business Owners Testify on U.S. Economic Growth
The Senate Small Business and Entrepreneurship Committee holds a hearing on tax policy, artificial intelligence, and other issues impacting small businesses.
A Seemingly Rock Bottomless Glass
Just when you think it can’t get any worse…A comically pathetic 8th inning turns a possible actual win into just another disheveled loss and the “free fall” stats keep mounting. It’s hard to believe that on June 19th the A’s were 38-38, winning percentage that would earn them a spot 1.5 games out of 1st […]
Royals 8, Twins 2: A bad baseball game
The Twins couldn’t hit Randy Dobnak, again, and their pitching and defense was severely lacking.
A.J. Epenesa not inclined to discuss "weird situation" with Browns
Before Eagles defensive end A.J.
Minding Your Business- Bill Hanney’s Entertainment Experience
“It is just incredible! We went all out,” said Bill Hanney, owner of the brand new entertainment mecca on Cape Cod: Bill Hanney’s Entertainment...
The Beauty Of Settled Science
Commenters convinced me I made a subtle mis-step in my framing of Psychology Research Is Mostly Fine. My framing emphasized that social priming studies had failed to replicate, but that many other subfields of psychology hadn’t. This naturally led commenters to point to failed replications in other subfields. Although none of these were as bad as social priming, few or none were entirely problem-free. Instead of emphasizing the difference between social priming and other subfields, I should have emphasized the difference between settled science and novel research. Here are some of my favorite psychology findings: The brain is sculpted by reinforcement learning, and a key driver of this learning is a prediction-error-based algorithm located in the nucleus accumbens and implemented through dopamine. Psychedelic drugs exert their effects through 5-HT2A receptors, pointing to a role for these receptors in some sort of construct like the balance between priors and new evidence. Certain cognitive functions are localized to certain brain areas (for example, impulse control to the frontal lobes; linguistic structure to Broca’s area, linguistic meaning to Wernicke’s area. But injure one of these areas, or render a certain function useless (eg a blind person having no more use for their visual cortex), and these mappings can gradually shift - suggesting that neurons are general-purpose compute whose specialization is a contingent fact about convenience and efficiency rather than a necessity. Most personality traits and general capabilities are about 50% genetic and 50% random, with little role for family environment or childhood history, with a few notable exceptions like partisan preference. Recent research complicates this story, but the further you go from this basic picture, the gnarlier the chains of indirect causation you require. Neurons fire together in “brain waves”, whose exact frequency corresponds with the character of consciousness; These divide neurons into natural subpopulations and linked graphs. The gamma rhythm corresponds surprisingly well to items in conscious awareness. GABA receptors seem to be involved in something like relaxation. By hitting different GABA receptors in different ways, you can modulate the exact type of relaxation you produce. Hitting GABA-A directly is too powerful and can cause dangerous levels of sedation, but allosteric modulation of GABA is an incredibly fruitful strategy that underlies drugs from benzos to barbituates to alcohol. If you know your GABA-A subunits, you can target specific subtypes of relaxation; for example, Ambien hits GABA-A1 and induces sleep. Memory divides somewhat fuzzily into bins of immediate-sensory, short-term, and long-term, with separate retrieval and storage functions, and separate systems for declarative vs. procedural learning. These can be harmed selectively, usually by hippocampal injury, so that some patients can remember their life stories but not form new long-term memories, or learn new skills like bike-riding but not new facts. The exact substrate of memory is unclear but seems to involve new synaptic connections between neurons in at least some way. The ability of modern psychology and psychiatry to treat mental illness is real but limited. SSRIs work for half or slightly fewer than half of patients; antipsychotics work with extreme side effects; benzodiazpines work but produce addiction and tolerance in many (not all) people. Most supplements are stuck in Poor Quality Study Replication Crisis Hell, but melatonin and l-theanine stand out as especially promising. Psychotherapy works with moderate effect size, but (with a few exceptions) seems to be more about the relationship with the provider than the details of the therapy itself. Mental hospitalization can sometimes defuse immediate crises but work less well than mental hospitals would like, with some studies showing overall negative effects. Schizophrenia is mostly genetic, but risk also increases with prenatal infection (especially rubella) and obstetric complications; there is suggestive evidence for roles of social stress and drug use (with psychedelics and marijuana making things worse, and nicotine if anything making things better). Bipolar and schizophrenia are so closely linked on a pathophysiological level that it seems like they might be the same disease; on the clinical level, they do seem to follow two separate courses/prognoses but can sometimes surprise clinicians by eg someone who seemed condemned to permanent schizophrenia unexpectedly recovering. The brain’s native reinforcement learning algorithms cash out in the phenomena of classical and operant conditioning; different reinforcement schedules reinforce at different levels, which can be exploited by bad actors to make especially compelling products (eg slot machines). None of these are immune to doubt. A few are speculative; one or two are genuinely unorthodox. But they’re all a step above one p = 0.049 paper that might not replicate. If they get overturned, they’ll be overturned by the same sort of genuine scientific shift that replaced Ptolemy with Copernicus or Lamarck with Darwin, not some sort of sordid discovery about someone entering random numbers into a spreadsheet. In 2008, Eliezer Yudkowsky wrote about The Beauty Of Settled Science: If you only care about scientific issues that are controversial, you will end up with a head stuffed full of garbage. The media thinks that only the cutting edge of science is worth reporting on. How often do you see headlines like “General Relativity still governing planetary orbits” or “Phlogiston theory remains false”? So, by the time anything is solid science, it is no longer a breaking headline. “Newsworthy” science is often based on the thinnest of evidence and wrong half the time—if it were not on the uttermost fringes of the scientific frontier, it would not be breaking news. Scientific controversies are problems so difficult that even people who’ve spent years mastering the field can still fool themselves. That’s what makes for the heated arguments that attract all the media attention. Worse, if you aren’t in the field and part of the game, controversies aren’t even fun. Don’t be embarrassed to read elementary science textbooks, either. If you want to pretend to be sophisticated, go find a play to sneer at. If you just want to have fun, remember that simplicity is at the core of scientific beauty [...] A steady diet of science news is bad for you: You are what you eat, and if you eat only science reporting on fluid situations, without a solid textbook now and then, your brain will turn to liquid. Psychology isn’t centrally the new paper in Annals Of Recently-Breaking News saying that an n=5 study showing that large portion sizes increase support for terrorism. Psychology is centrally ideas like brain waves, GABA receptors, reinforcement learning, twin studies, and connectionism. People who think differently are worrying too much about BREAKING NEWS!!!, and should stop. The key distinction isn’t “recent research in social psychology” vs. “recent research in cognitive/bio/behavioral psychology”, as my essay last week unfortunately implied. It’s recent research in general vs. the deposit of settled science, battle-tested hypotheses, and carefully-earmarked speculation. And part of the reason social priming in particular was such a disaster was that it defied that heuristic, building itself up over hundreds of studies until it approached or even entered the pantheon of settled science - before collapsing (5-HTTLPR was also sort of like this). This isn’t a claim that settled science is always right - Freud was “settled science” for a long time - just that there’s an intuitive distinction between the level of credence you should have in the existence of power posing vs. the existence of Broca’s Area. (I compounded this error by calling the last post “Psychology Research Is Mostly Fine”, which suggested I was talking about the new research rather than the settled science. I actually meant to distinguish between research-psychology-the-field vs. clinical-psychology-aka-therapy, but this framing unintentionally pushed against the point I wanted to make) Some commenters on the previous article understood this point, but challenged its weight. It’s very cool, they said, to know how many neurons are in which brain lobe, but the main way that Psychology affected their lives was through bad clickbait studies used to buttress dumb policies; some p = 0.049 study says that exposure to microaggressions makes minorities’ brains shrivel into raisins, and now their company has to implement punitive DEI or be sued for hazardous work conditions. I won’t dispute this as an accurate description of how the sausage gets made, but it’s worth examining the trains of thought that connect this observation to a campaign against psychology in general: The dumb woke psychology was wrong and bad, and I don’t have good heuristics for distinguishing dumb woke psychology from other psychology, so I’m going to assume it’s all wrong and bad. The dumb woke psychology was wrong and bad; it seems useful to punish/discredit psychology as a whole to assist my campaign against it, so for propaganda purposes I will try to discredit psychology as a whole. To people in the first camp, my response is: come on, your heuristics aren’t that bad. “Microaggressions makes minorities’ brains shrivel up like raisins” is in the woke category; “the hippocampal theta rhythm seems to be associated with both memory and pathfinding, suggesting an unexpected yet surprisingly compelling relationship between the two” is in the not-woke category, don’t play dumb here. To people in the second camp, my response is: deliberately exaggerated propaganda campaigns are bad and this is a confession, not an excuse. Inability to view science through anything but a political lens was what got us into this problem; doubling down on it is a temporary solution but a recipe for permanent disaster. If you pronounce entire fields of science to be acceptable collateral damage in your campaign against bad political actors, you will alienate not just scientists but patients, clinicians, and general lovers of truth. Instead, you can say the thing you mean - that woke partisans shouldn’t try to occupy and exploit the otherwise-noble science of psychology for their own political gain - and wage the same campaign with a halo rather than a comic-book-villain goatee. From the font of oracular wisdom that is Weird Sun Twitter: [ Vessel Of Spirit@VesselOfSpirit i love you all conditionally but i love the good part of you unconditionally. even if it becomes a very small part 2:11 AM · Jan 22, 2015 1 Reply · 5 Reposts · 29 Likes ](https://x.com/VesselOfSpirit/status/558084551772471298) This is how I feel about psychology1, too, but with a touch more optimism. The good part of psychology is enormous, a hoard of endless treasures. You just have to look past the headlines! 1 To play devil’s advocate - should one always be so magnamious? Astrology? Phrenology? These seem different in that their entire orientation was flawed from the start; they didn’t simply fail to find the correct constellation-personality connections, the whole project of searching for connections between constellations and personality was doomed from the start. More difficult might be asking the same question about education research, which is notoriously bad. I don’t know enough about education research to know if there’s some settled science of correct and enlightening results lurking in the background beyond the day-to-day froth of poorly-conducted and politically-motivated studies. I think if it’s 90% bad, 10% good, it’s correct to call it bad as a compact way of communicating a useful truth; I think psychology is better than that, but admit it’s a tough judgment call.
Rady Children’s Health Named Official Pediatric Healthcare Partner of San Diego FC and San Diego FC’s Right to Dream Academy
San Diego FC announced today a deeply integrated, multi-year partnership with Rady Children’s Health. Rooted in a shared commitment to youth wellness, the partnership brings together two trusted and local organizations focused on supporting the health, mental well-being, and joy of children across the San Diego region. “A club is
MrBeast Sales Slow, Angel Stock Falls, MUBI and Neon Look for Hits, and Will an NBA Franchise Set a Sales Record?
(Welcome to the Entertainment Strategy Guy, a newsletter on the entertainment industry and business strategy. I write a weekly Streaming Ratings Report and a bi-weekly strategy column, along with occasional deep dives into other topics, like today’s article. Please subscribe.) You probably remember egg prices spiking a few years ago. This led to a lot of debate between the pro-market/pro-competition/antitrust/Neo-Brandesian crowd and the center/center-right/center-left/abundance/libertarian crowd over the cause, whether it was the avian flu outbreak or whether industry consolidation led to price fixing, using avian flu as a convenient cover. Basel Musharbash wrote a whole investigation at BIG looking at it. Well, two years later, we have our answer: it was price fixing. The Justice Department found proof, via emails, of price fixing. Indeed, just the threat of an investigation brought prices down two years ago: I bring this up because at least half a dozen of my favorite political writers and pundits, who were skeptical about price fixing at the time, haven’t written any mea culpas on this issue. It’s really dispiriting and makes it much, much harder to trust their work on other issues. If you take a hard stand on an issue, then you get it wrong, you need to explain how and why you got it wrong. Or update your priors. This is how epistemological bubbles are formed! All of which is to say, it’s time for another installment of “What I Got Right, What I Got Wrong”. Last issue, I mostly focused on the “wrong” side of the equation, so today’s is a bit more balanced, but with one big mea culpa (though I still stand by my original concerns). Let’s dive right in! Subscribe CORRECTION: UFC Didn’t Release Subscriber Data (But Seems to Have Bragged About It Internally) In my analysis of the viewership of UFC Freedom 250, I wrote... “Paramount has also released datecdotes bragging about their subscriber numbers. Earlier this year, they claimed that the first UFC fight on Paramount+ brought in 1 million subscribers.” Well, that datecdote did not come from a PR rep, but from great reporting from James Faris at Business Insider. The actual quote was this: “Paramount’s flagship streaming service generated about a million new subscribers on the day of its first-ever UFC event, Paramount product chief Dane Glasgow told employees in a town hall on Tuesday morning, three staffers who attended the meeting told Business Insider.“ This wasn’t the biggest goof in the world; even Faris emphasized to me that this is more a “clarification” than a correction. Still, it sounds like, internally, the folks at Paramount were very happy about this result—and I’m guessing they were happy with this news getting out—even though the gains didn’t last through the quarter, dropping to 700K adds. RIGHT: MrBeast’s Struggles Continue... I’m very skeptical about MrBeast’s burgeoning media “empire” and, in particular, its $5 billion valuation, as I wrote earlier this year and last year. Sure enough, according to Business Insider, regarding its “booming” consumer products division_:_ “US sales volume grew 13% year-over-year in 2025, following a 33% leap the previous year, according to a presentation deck dated May 2026....A February 2025 investor deck viewed by Business Insider showed Feastables’ net revenue more than doubled in 2024 from 2023, to $215 million, and was forecast to grow 74% in 2025, to $375 million.” [Emphasis mine.] If you told investors that you projected 74% growth but delivered 13%,1 that’s not ideal. But it’s not just MrBeast. Logan Paul and KSI’s Prime had sales drop in half for their energy drinks. It’s one thing to build a successful entertainment company and an entirely different thing to succeed in the heavily-consolidated-but-also-very-competitive consumer packaged goods space! CPGs are dominated by a few firms with very wide moats compared to YouTube, which has few barriers to entry. These businesses require different skill sets and have completely different business environments. WRONG: Does the NBA Have an $8 Billion Bidder? Almost as soon as I published my article about the NBA’s finances, casting skepticism on NBA expansion, I saw this Front Office Sports headline: One group “claims to have already raised $8 billion” for the Vegas expansion team. I mean, wow. That’s just $2 billion less than what the Los Angeles Lakers were valued at when they were sold just last year. And they’re arguably the most popular team in the NBA. (Side note: the new owner is now under an investigation for fraud in how he went about financing the Lakers and the Dodgers purchases.) So much for the “dried up” language I used in that article. (This is why I usually stick to my “Entertainment Nuance Guy” tone in articles...) I went off old information—from April, when I read/heard about the NBA downplaying expansion efforts—instead of doing a quick double-check for new news. That said...if you read the article, the market for Seattle is “slow”, with just one reported bidder. So I wasn’t entirely off. This goof has annoyed me since I first published it, mainly because it undercut that article’s real point, which I stand by: NBA franchises are really overvalued right now. Now, I get why NBA teams are overvalued. When it comes to owning sports teams, it’s basically never wrong to assume that some rich person somewhere will care more about owning a team (or just being part of a group since they’re so expensive) than the actual financials. There are only so many teams to own, and opportunities to buy in preferred markets don’t come along very often. This explains why the teams sell for such high multiples (usually above a 10 to 12.5 revenue multiple, which is very high). You only need one person to overpay! Beyond the ultra-wealthy luxury good explanation, I worry NBA teams are becoming speculative assets. More and more private equity investors are buying into NBA teams. But the value, in owning a team, comes from selling it later, not any meaningful relationship to revenue or profit growth. In other words, the newer NBA owners are increasingly expecting someone later to buy their inflated asset. That’s not sound economics; that’s the “greater fool” theory at work.2 At some point, actually making money has to matter. Especially since revenue growth is now below the growth of the stock market. (And this matters because the NBA doesn’t have easy levers to pull to drastically lower their costs—half of their revenue has to go to players and then you actually have to run a team, including coaching, training, travel, media expenses, and more—or raise revenues aside from one-off expansions in America and overseas.) I just don’t see how investors make their money back buying NBA teams, except for selling at a higher price later on down the line. But if revenue/profit growth continues to slow, at some point, someone will be left holding the bag. RIGHT: Baseball and Basketball are about equally popular. Related to the above, I wanted to cite two quick pieces of evidence for one of my other theories: that the NBA and MLB are about as popular as each other, but the NBA gets much, much better media coverage. One YouGov survey has that fans prefer basketball to baseball by 52% to 48%, which I’m guessing is within the margin of error for that poll. That’s virtually even, meaning they’re about the same popularity. Over on NBC, a recent Red Sox-Yankees game averaged 4 million viewers, higher than Sunday Night Basketball’s average of 3.4 million on the same network. A Yankees-Dodgers game averaged 3.9 million two weeks ago. Not every game averages this much, but it shows you that baseball isn’t far off from basketball, depending on the matchup. Altogether, the NBA is just slightly more popular than baseball, but NBC is paying MLB a fraction of what they pay the NBA, a point I’ve made before. RIGHT: Angel, MUBI and Neon Updates... I’ve long been skeptical about many of Hollywood’s buzziest startups/smaller indie studios. It’s not that they don’t make great movies—films like Anora and Everything Everywhere All at Once are amazing—or that they’re not (rightfully) pushing the majors to make better films, but...they get a ton of hype, and that hype often doesn’t live up to the reality or difficulty in scaling up. Starting with MUBI, well, The Wall Street Journal wrote a feature on MUBI’s struggles last April, best summarized by the subheader “After Sequoia valued Mubi at $1 billion, a left-wing revolt sent the indie film company into a tailspin”. MUBI lost $7.3 million on $200 million in revenue in Q4 2025, but reportedly hit a record 1.7 million subscribers at the end of Q1. As for Neon, Department M purchased a “significant stake” in the company earlier this year. How much is that “stake” worth? According to Deadline, “No financial figures for the Neon-Department M deal were disclosed.” So...that’s not great! If it was a big valuation, we’d hear about. Also, I found this curious: “Both Neon and Department M already have separate partnerships with Qatar. The Qatar Film Committee has a slate deal in place with the former, and a biopic production pact with the latter.” Color me skeptical about much Middle Eastern investment dollars. See: LIV Golf. Finally, as for Angel (formerly Angel Studios), their stock very, very slightly popped last month after Young Washington ($20 million budget) which made $45 million in the US, but their stock is still way down from its opening. Smaller Updates RIGHT: The WGA should focus on antitrust concerns! I’ve been on this for years. Post-WGA/AMTPT deal in 2023, I wrote an article for the Ankler calling on the WGA to focus and organize against industry consolidation. Sure enough, the WGA filed a lawsuit against the Paramount-WBD merger, and people are organizing around this issue now. I wish this energy had coalesced earlier (specifically to lobby Washington much earlier), but better late than never! WRONG: Actually, the chip shortage might be due to market manipulation. In my last “Long Reads for the Long Summer” article, I shared an article about how LLMs are causing memory chip prices to spike, which will make all electronics more expensive. Well, turns out, three RAM manufacturers control 90% of the market, and now a private lawsuit accuses them of price-fixing. So yeah. WRONG/UPDATE: The Odyssey will hold! Two weeks ago, I wrote, “As of this moment, we haven’t had a super-blockbuster, though The Odyssey, Spider-Man: Brand New Day and Avengers: Doomsday could all cross the $500 million mark. (At this point, The Odyssey would need a very strong hold to get there.)” Well, it’s safe to say it’s going to have that hold! It only dropped 30% in weekend two and IMAX screenings are sold out all month. Spider-Man: Brand New Day is also off to a great start. RIGHT: People are rushing to get shows out yearly. I’ve long been bullish on yearly, weekly-released shows, and Leslie Goldberg at The Ankler wrote about how many people in town are now listening. WRONG: Mark Carney reverses Canada’s stance on homegrown production. After writing about Canada installing domestic production quotas, Canada has backed off. WRONG: I don’t trust Spider-Man: Brand New Day’s online “views”. When I originally wrote about the latest Spider-Man film’s record-breaking trailer, I thought this was just YouTube views, but after watching this Corridor Crew video and doing more research, well, it’s all social views of the trailer globally. Really? That stat includes TikTok, Reels and YouTube Shorts views. Basically, I don’t trust it anymore. (This film will probably set record, but I trust the pre-sales data more.) RIGHT: Celebrity Production companies are still struggling. I’ve written about this for years, but the company that I didn’t track was Kevin Hart’s HartBeat, which was valued at $650 million but is struggling now and might just end soon, especially after Kevin Hart pulled his endorsement deals. And Bad Robot is moving to NYC. CORRECTION: SpongeBob is a “second run” title. In my 2025 recap article, I had _SpongeBob SquarePants_labelled as a “library” title, when it is still a “second run” show, with new episodes still coming out on Nickelodeon. CORRECTION: In my last “What I Got Right, What I Got Wrong” update, I offered a correction from Doug Creutz and misspelled TD Cowen. Thanks, Grammarly! 1 Though he could have increased prices to make up for the gap, he couldn’t have increased them that much. 2 There’s a theory, which I think that Daryl Morey created and Bill Simmons popularized, that, to be successful building your team, you only need a handful of bad GMs in the league to take advantage of. To be clear, Daryl Morey’s theory was also for signing bad contracts, that you could always get out of bad contracts. Basically, there’s always someone who will make a bad trade. It’s not the same exact thing, but similar enough to the Greater Fool Theory that I really like it.
Navy Suddenly Ends 43-Year Blue Angels Uniform Deal with Florida Business
The Navy ended the Sewing Box’s four-plus decade deal and awarded a $1.69 million contract to a Virginia defense contractor.
Yankees call up George Lombard Jr.
BRONX, NEW YORK(WBRE/WYOU)— With the MLB Trade Deadline behind the organization, the New York Yankees made improvements to the big club Monday night, internally. The Yankees are calling up top prospect and Scranton/Wilkes-Barre RailRiders shortstop George Lombard Jr. The Yanks #1 prospect started this season in Double-A Somerset. Lombard was called up to Scranton/Wilkes-Barre in […]
Stakeholders Testify on Medicaid & Health Care Costs
Stakeholders testify on Medicaid, the cost of care, and program funding needs bedore the Senate Budget Committee.
MLB trade deadline: The best non-Tarik Skubal moves
The Dodgers caught the white whale at the deadline, but plenty of other trades will have an impact
Kustom Entertainment Closes $6.1 Million Divestiture of Legacy Video Solutions Business to Cycurion
Completes strategic transformation into a pure-play live entertainment and ticketing technology company; Secures $1.25M upfront cash, $4.25M secured...
Wirtz family sells Lakeview apartments for $34M
The Wirtz family's real estate business has sold a vintage apartment tower in Lakeview for $34 million in its latest move to pare down its residential holdings.
Yankees' MLB trade deadline period misses the mark
In all, Yankees GM Brian Cashman swung three deals leading up to Monday's deadline, obtaining two big-league hitters in Heliot Ramos & Luis Garcia Jr.
New York Yankees Announced Carlos Lagrange Update Before Cardinals Series
On Monday night, the New York Yankees hosted the St. Louis Cardinals in the Bronx for the first of their three-game series.The Yankees lost by a score of 13-7.New York Yankees Announced Carlos Lagrange UpdateAhead of their series with the Cardinals, the Yankees announced the latest update on Carlos Lagrange.MLB.com wrote (on August 3): “Has […] The post New York Yankees Announced Carlos Lagrange Update Before Cardinals Series appeared first on HEAVY.
UMass Chan receives Massachusetts Life Sciences Center funding to advance health equity in pregnancy care and biomedical discovery
UMass Chan Medical School researchers have received funding from the Massachusetts Life Sciences Center to advance research using artificial intelligence to improve early identification of pregnancy-induced hypertension and to establish a colorectal cancer biobank that will accelerate biomedical discoveries.
Stakeholders Testify on Medicaid & Health Care Costs
Stakeholders testify on Medicaid, the cost of care, and program funding needs bedore the Senate Budget Committee.
Apple is finally closing a significant ecosystem gap with Android on Windows
Apple plans to let iPhone users copy and paste seamlessly with Windows PCs, years after Android users got similar functionality.
Tigers’ Jack Flaherty Goes Viral For Heartbreaking Reaction After Trades
The 2026 MLB Trade Deadline is officially in the books, and the Detroit Tigers have made multiple moves involving high profile players.On Saturday evening, they traded away ace pitcher Tarik Skubal, the back-to-back American League Cy Young Award winner, to the reigning World Series champion Los Angeles Dodgers. Additionally, not long after designating him for […] The post Tigers’ Jack Flaherty Goes Viral For Heartbreaking Reaction After Trades appeared first on HEAVY.
MLB trade deadline winners and losers: Dodgers, Cubs and Padres all go big, while the Mets sell nearly a third of their roster
2026 MLB trade deadline winners and losers: Giants, Mets enjoy seller's market, Yankees don't do enough
The 2026 MLB trade deadline is in the books; there were a lot of deals and a handful of winners and losers
Trade Deadline: What Seattle Mariners' AL West rivals did
A look at how the 2026 MLB trade deadline shook out for the Seattle Mariners' AL West rivals, including the first-place Houston Astros.
Dodgers trade for 2 former catchers immediately before MLB deadline
The Dodgers got the band back together
MLB Trade: Chicago Cubs Acquiring Angels’ 3-Year MLB Reliever
After their nixed trade with the Los Angeles Angels for Reid Detmers, which has not been confirmed yet, the Chicago Cubs are back on the board with a meaningful move. According to ESPN’s Jeff Passan, the Cubs are acquiring RHP Ryan Zeferjahn from the Angels. Passan wrote: “The Chicago Cubs are acquiring right-handed reliever Ryan […] The post MLB Trade: Chicago Cubs Acquiring Angels’ 3-Year MLB Reliever appeared first on HEAVY.
Ariana Grande is extremely thin. Is it any of our business?
The singer appeared emaciated in a new video and has said she’ll soon “step back from visibility.” Cue the criticism and concern.
The Thrill Returns! MLV Is Back In Vegas
Major League Volleyball is back in Las Vegas, as the Vegas Thrill has officially announced it will return to the court in 2027.
Red Sox Land Adley Rutschman in Stunning Al East Blockbuster
The Red Sox just acquired catcher Adley Rutschman from the Baltimore Orioles, per Jeff Passan. The 28-year-old switch-hitting catcher was the first overall draft pick of the 2019 draft. Multiple outlets confirmed the rare AL East Blockbuster with multiple prospects traded in return for Rutschman. The Orioles will receive C Carlos Narváez. Other names include MLB’s No. […] The post Red Sox Land Adley Rutschman in Stunning Al East Blockbuster appeared first on The Lead.
MLS Taps Private Equity Veteran As Next Commissioner
Don Garber had led the league since 1999.
Upcoming Science Cafe
BAR HARBOR—Join us for a fascinating Science Cafe with environmental toxicologist Nishad Jayasundara, Ph.D., as he explores how everyday contaminants and other stressors such as heat exposure may be quietly influencing kidney health. Chronic kidney disease (CKD) affects nearly 1 in 7 adults in the United States—and more than 840 million people worldwide. While factors like diet and genetics are well known, scientists are increasingly uncovering another important piece of the puzzle: environmental exposure. Drawing on his team’s research, Dr. Jayasundara, Maine INBRE alum as a College of the Atlantic undergraduate student and past MDI Bio Lab Visiting Scientist, will share how early-life exposure to environmental toxins can disrupt kidney development, and may affect kidney structure and function in adults. Blending cutting-edge research with real-world relevance, this Science Cafe will shed light on an important and often overlooked contributor to human health—and what it could mean for communities around the world. Monday, August 17, 2026 at 5 p.m.Hybrid event at Maren Auditorium and via Zoom Register Now What Are Science Cafes? MDI Bio Lab’s Science Cafes provide an informal introduction to ground-breaking biomedical research by its scientists, scholars from near and far and from local experts in other fields as well. Each Cafe lasts about one hour; the floor is open for questions and discussion. It can get lively and it’s always engaging. MDI Science Cafes are open to the public and free of charge. For more information, or to watch past events, visit our website. The MDI Science Cafe Series is brought to you by Cross Insurance. Subscribe Share Leave a comment
Press Release: Atlanta Braves Honored with IDEA Golden Matrix Award for Best Overall Production in Sports
The IDEA Golden Matrix Award for ‘Best Overall Production’ represents the best game presentation in professional sports and is voted on by teams across professional sports in North America The Atlanta Braves’ Fan Experience team was recently honored with the 2026 Golden Matrix Award for ‘Best Overall Production’ by the
Philadelphia Phillies Acquire 4-Time All-Star in Blockbuster Trade
The MLB trade deadline is set for Monday at 6 p.m. ET, giving teams just a few more hours to make any significant, season-altering moves. The Philadelphia Phillies wasted little time Monday morning, pulling off what could be one of the biggest deals before the deadline in a blockbuster trade with the San Francisco Giants. […] The post Philadelphia Phillies Acquire 4-Time All-Star in Blockbuster Trade appeared first on HEAVY.
If Not AOC, Then Who?
What do we do if Alexandria Ocasio-Cortez decides not to run for president in 2028? It makes sense that many leftists are currently focused on calling on her to take the plunge. But the absence of a Plan B, or even much discussion about one, is worrisome. The US Left can’t afford to sit out the 2028 Democratic primary. Doing so in 2024 was a disaster: our abstention self-marginalized anti-billionaire politics from the national conversation and thereby gave space for Harris to pivot to the “center” (i.e. the policy preferences of corporate donors, establishment hacks, and AIPAC). Abstaining again in 2028 would be especially counterproductive since democratic socialists now have so much wind in our sails after our big electoral wins in NYC and across the country. It’s time to deepen our momentum, organization, and profile — not to retreat to the margins during America’s single most important political battle. Even more urgently, keeping Trump’s heir out of the White House may depend on whether leftists and the party’s unprecedentedly disenchanted base can force the Democrats in 2028 to take meaningful steps towards a very angry electorate and away from the corporate-consultant blob that has helped get us into this mess. If AOC (or Abdul El-Sayed) decides to run, we should enthusiastically go all in — DSA, fighting unions, progressive organizations, anybody who wants to see a better country and world. But, as far as I can tell from the outside, there’s a real chance that she doesn’t run. And we can’t just wait and see where she lands before discussing alternatives, since AOC’s decision might not come for quite a while, giving us little time to scramble at the last minute for an alternative. So we should start working now on getting a Plan B into motion, and recruiting a good candidate for the role. Here’s one idea. A Worker Candidate — Healthcare Not Warfare 2028 Run a union worker Leftists don’t need to always run experienced, well-known socialist politicians for high-profile contests. Lula, the current president of Brazil, began his political career as a metalworker militant who ran for governor of São Paulo in 1982. Especially in an era of institutional distrust, it’s possible to lean hard into making a virtue out of a working-class comrade’s distance from traditional politics. Experience abroad shows this clearly. Rachel Kéké — an immigrant hotel housekeeper — ran as the candidate of the leftist La France Insoumise for the National Assembly in 2022, defeating a former minister in the Macron government. The Belgian Workers’ Party in 2024 won its first Flemish seat in the European Parliament by running Rudi Kennes, a three-decade veteran of the Opel Antwerp auto factory. And the South Korean left in 2024 elected auto factory militant Yoon Jong-oh to the National Assembly. If a tiny French Trotskyist organization could make such a big splash in 2002 and 2007 by running a well-spoken postal worker cadre for office — the LCR’s Olivier Besancenot received about 1.5 million first-round votes — it’s not far-fetched to expect that a much larger organization like DSA, together with a broader coalition of the willing, could run this playbook to much greater effect. This is especially the case now that almost everything DSA does immediately becomes a national news story. We don’t need someone famous. We just need a charismatic, well-vetted comrade who works in a relatable working-class occupation — e.g. a nurse, or a worker in auto or construction, or at Amazon. Ideally, they have a compelling personal story or have been part of a significant strike or organizing campaign, but even those criteria don’t necessarily have to be deal-breakers. The main lesson of the Graham Platner fiasco isn’t that we should never run outsiders for office (the momentum he generated proves the exact opposite), but that they need proper vetting and roots in democratic membership organizations like DSA or a union. In any case, there are plenty of ways to signal working-class authenticity without resorting to Platner’s or Fetterman’s performative macho white dude affect. Better to have someone of any gender or race who is actually working class, with firm socialist politics, who can speak from experience about the day-to-day realities of trying to make it in America. There are surely at least a dozen such worker leaders in our movement nationwide; we just need to sit down and convince one that their personal sacrifice for the greater good (i.e. running for president) will be worth it. If we don’t have a frontrunner with a clear path to victory like AOC (or El-Sayed, were he to win Michigan), it’s better to embrace someone whose decision to run in itself tells an important story about US politics: workers have been iced out of our political system and are now fighting hard to break back in. The novelty factor, in itself, would generate press. And it would help democratic socialists signal to the American public that our movement’s defining characteristic is that we represent workers vs. bosses, not that we’re “the furthest left” force in American politics — a framework that suggests we’re extremists and that helps our opponents isolate us from non-college-educated voters by highlighting extremely minoritarian (and misguided) stances included in DSA’s platform like prison abolition. We don’t get many opportunities to speak to tens of millions of Americans; we need to use these opportunities to broaden our appeal beyond those already in our orbit. Run to polarize the 2028 primary and general election around “Medicare for All” and “End All Aid to Israel” Why should democratic socialists use our scarce time and volunteer energy to run in a race we’re unlikely to win? Running in the 2028 primary will not only recruit us scores of members (imagine having a DSA member intervening in eleven nationally televised primary debates!), but — more importantly — it has the potential to be a decisive leap forward towards an America that finally starts meeting the needs of working people instead of HMO and AIPAC billionaire donors. Polarizing litmus tests are good, actually — as long as they’re fought for around popular demands in a thoughtful and strategic way. Democratic socialists have an opportunity and responsibility to make the 2028 primary about two of the most widely and deeply felt issues of our moment: domestically, America’s unaffordable, family-breaking private healthcare system; internationally, America’s bankrolling of the genocidal Israeli government. A candidacy relentlessly demanding Medicare for All and No Aid to Israel would pose a sharp question to the American public, the Democratic Party, and other 2028 contenders: Why can’t working-class Americans afford their healthcare bills at the same time that our government is spending at least $3.8 billion yearly to fund an Israeli regime eager to keep dragging us and the world into more forever wars? Our candidate can agitate around a clear message: I’m running to give voice to all those working-class Americans who are struggling to get by. No matter what state you live in, who you voted for in 2024, or your background, it’s just plain common sense that we should make healthcare more affordable instead of spending billions to enable the Israeli government’s crimes against humanity. Every American who agrees with me when I say ‘Medicare for All — Not a Dime for Israel’ should make their voice heard through our campaign. Racking up a high number of votes for this agenda is a crucial way to show the Democratic Party and the country as a whole that we can’t keep supporting a life-destroying status quo in our healthcare system and in the Middle East. If we want to defeat Trump’s handpicked crony this coming November, we need to speak to ordinary people’s frustrations with the status quo — we can’t keep running the same tired establishment playbook and expecting a different result. For those highly engaged voters (or skeptical media pundits) who raise concerns about wasting votes, the candidate can take the time to explain why this isn’t the case: It's true I'm a long shot. But Zohran showed anything can happen — and voting for me is a pragmatic decision, not a wasted vote. In a heavily divided primary with a large number of candidates and a very discredited establishment, my campaign and the democratic socialist movement I’m part of are positioned to be the balance of power if we can get a large enough number of voters to loudly demand Healthcare Not Warfare. Since there’s a high chance no candidate will get to 50% in the 2028 primaries, the Democrats could very well be heading towards a brokered convention, where a disciplined, principled current committed to breaking from corporate donors can play an outsized role in making sure whoever ends up with the nomination raises the banner of single-payer healthcare and cutting aid to Israel. How exactly could running this sort of primary campaign be translated into actual leverage? The candidate replies: I’m aiming to win the nomination, but if I don’t achieve that goal, my delegates and I will pledge our support in the primary only for a candidate who agrees in the general election to call for ending US aid to Israel and establishing Medicare for All at home. These are both winning planks for November against the Republicans, and the only reason I can see that other candidates haven’t yet raised these is that they’re still more scared of the donor class than they are of the people. That needs to change. If Democratic leaders want young people, workers, and those sick of the status quo to show up in big numbers this November, they need to meet us halfway. In this way, whether or not we win the nomination, democratic socialists could still play a decisive role in 2028. The approach outlined here is similar to what radical left parties periodically do in parliamentary democracies like Denmark or Sweden when they find themselves as a junior partner electorally: they dictate to center-left allies what their terms would be for enabling, from the outside, the formation of a new government. Running a Healthcare Not Warfare candidate will make it significantly more likely that the 2028 Democratic candidate stands with ordinary people instead of donors on these two pivotal planks — a shift that will, in turn, make it easier to achieve the existentially important task of defeating MAGA’s heir in November. Look at how much popular traction the Uncommitted movement got with a similar strategy in 2024 with so little on-the-ground organization — surely we can go much further with a working-class candidate, a much bigger DSA, and a Democratic Party base that has turned against Israel, billionaires, and the hacks in the party who prop them up. Objections and Responses There are quite a few objections to this proposal, many of which are very reasonable. Let me briefly address each here. Socialists shouldn’t waste their scarce time and resources on a candidate unlikely to win. This is a good rule in general, but there are important exceptions, and presidential elections are the main one. There’s no other political contest that gets anything like this level of attention and engagement in the US, so if you want to be a serious force in nationwide politics, you basically can’t afford not to have a candidate. Far from being an overall drain on our resources, running a dynamic 2028 campaign would likely result in a major net increase in members and capacity. In that spirit, the very pragmatic Milwaukee sewer socialists — who mostly ran to win at home in Wisconsin — supported Eugene Debs’s propagandistic presidential campaigns, which they correctly saw as a crucial means of recruiting to the Socialist Party. And now that the (post-1972) Democratic Party gives more weight to voters than party operatives in determining its presidential nomination, it’s become feasible to run as a socialist in primaries without risking a split in the vote against the Republicans in November. We should just support Ro Khanna, who also supports M4A and ending aid to Israel. I like Ro Khanna and would enthusiastically vote and canvass for him for president were he to get the nomination. But there’s a real chance that Khanna’s bid for office doesn’t catch on; he lacks the grassroots organizational apparatus of DSA, and, because he’s not really of the Left or labor (despite his current very good positions), he’s unlikely to generate the type of buy-in and enthusiasm that a DSA candidate would. Moreover, Khanna would be running as an individual, not as someone emerging from and building an organized movement — his campaign would not likely focus on building sustained power from below, nor would it likely polarize the 2028 primary around M4A and Israel aid. Also, and not inconsequentially, the poor electoral results for Tom Steyer and Saikat Chakrabarti this spring suggest that there’s perhaps not much of a popular appetite in the Democrats’ base to support multi-millionaire class traitors. Much better, then, to run a democratic socialist worker. If by Super Tuesday it’s clear that our campaign has captured the main left lane in the primary, Khanna should drop out and endorse us; conversely, if he’s managed to capture this lane, DSA could at that point transform its Healthcare Not Warfare campaign into an independent campaign to elect Ro Khanna focused on winning (and holding him accountable to) those two critical planks. An openness to consolidating an anti-corporate candidate by Super Tuesday is a necessary component of the strategy I’m proposing, because otherwise we risk splitting the primary votes (per DNC rules, you need at least 15% to get any delegates to convention). We should convince Shawn Fain or Sara Nelson to run for president instead. I agree it’d be great if either ran for president, but my impression is that there’s basically no chance that will happen in 2028, because both are firmly focused on their union leadership duties (and, in the case of Fain, beating back a federal witch-hunt). This plan could have DSA end up endorsing a non-socialist, non-DSAer for president. That’s against our principles. It’s a myth, and bad politics, that socialists can’t ever support candidates who aren’t members of their organization and/or who don’t call themselves socialists. Bernie, after all, was not a DSAer. And socialists abroad regularly make tactical decisions about if and when supporting a non-socialist candidate makes sense from the standpoint of promoting working-class interests, defending democracy, and building a socialist current in the process. If your “principles” prevent you and DSA from helping achieve the momentous stride forward of having a Democratic candidate in 2028 run on Medicare for All and ending aid to Israel, those “principles” are not very good. In fact, they actively undermine the causes they’re aiming to support. We shouldn’t confuse principles (working-class independence) with tactics (the best way to advance this in a given context). In my recent article in Catalyst on Milwaukee sewer socialism (I’ve uploaded the full text here), I have a section showing how similarly rigid rules about endorsements had to be eventually discarded in the old Socialist Party nationwide after WWI because they tended to lead socialists towards a sectarian abstention from broader anti-corporate electoral insurgencies beyond their party’s control. For what it’s worth, Lenin’s current under Tsarism frequently backed bourgeois candidates in the second round of elections and Lenin himself advocated that British Communists support Labour Party candidates; for his part, Kautsky in 1912 defended the German Social Democracy’s electoral pact with the Progressives in the runoffs. If our predecessors could be that tactically flexible in an era before the limits of their underlying strategic assumptions about intransigent class politics in capitalist democracies were made clear, then there’s no need to insist on being more tactically rigid today, after a century’s worth of accumulated experience. As long as you maintain your own political profile and organization while engaging in broader coalitional efforts, there’s zero inherent contradiction with the principle of political independence. More specifically: DSA and allied organizations should enthusiastically back Michigan’s Abdul El-Sayed if AOC declines to run and he throws his hat in the presidential ring. (I have no idea whether he’s even considering this path, but there’ll surely be chatter about it if he wins his Senate race this November.) Though he doesn’t call himself a socialist, El-Sayed is a principled Berniecrat, a consistent fighter for Palestine, and would have a clear path to victory. Using the “s” word is far less important than whether a campaign fights for the interests of working people at home and abroad — and whether actively participating in it can grow the organized working class and the Left. And the same holds true if a less anti-corporate candidate were, under pressure, to adopt our two Healthcare Not Warfare planks. Why focus only on M4A and ending US aid to Israel? There are so many other important issues to fight for! Obviously there are many pivotal issues beyond healthcare and Israel, and our candidate — and especially our organizations involved in the campaign — should be prepared to speak on all of these. But one of the crucial lessons of the Zohran campaign is that you have to relentlessly stay on message if you want to cut through the noise. CNN and Fox News will want to talk about DSA’s views on Venezuela and abolishing the police; we need to polarize the debate on the widely and deeply felt issues that are most favorable for growing the Left, isolating our opponents, and winning urgently needed changes. One recent poll found 63% of Americans support M4A, even after respondents were told it would raise taxes and eliminate most private insurance. Another found that 74% of Democrats opposed “providing additional economic and military support to Israel.” And focusing on two demands sets the campaign up to be able to leverage its mandate to make clear demands upon other candidates (which we can’t do if we run with a laundry list of demands). Talking about a Plan B is a distraction from the more urgent work of building a groundswell of calls on AOC to run. It’s good for DSAers, fightback unionists, and progressive organizations to try to convince AOC to run. This proposal is meant as an addendum to pushes to get AOC to run and to line DSA up for that eventuality, not as a substitute for those efforts. But I’m worried that, like in 2024, we might eventually find ourselves with no time to find a viable alternative unless we start now. DSA, with its abundant deliberative processes, moves slowly. The approach you’re suggesting seems risky. If a DSA candidate runs but doesn’t receive a lot of votes, it’ll undercut our current national momentum. This is a reasonable worry. All big initiatives always carry risks, and the path I’m advocating is certainly not free of these. That said, if a Healthcare Not Warfare campaign doesn’t catch on like we envisioned, it’s a pretty simple pivot in March 2028 to explain that in the future we really need our standard-bearers like AOC, or our growing bench of national electeds, to step up in presidential primaries. Moreover, it’s worth noting that the risk of my Plan B proposal is on the whole significantly less than the risk entailed by an AOC run. We should all back her if she runs, since she’d fire up the base, provide huge openings for organizing, have a real shot at defeating a Republican (especially given MAGA’s unpopularity), be a great standard-bearer for our issues, particularly M4A and ending aid to Israel, and be less willing than mainstream candidates to capitulate to any anti-democratic machinations from Trump and co. But it’s also true that AOC could lose, which would be a devastating setback to the country and the Left. Or she could win and find herself unable to pass much, if any, of her (and our) program, a demoralizing prospect. So if we’re willing to take these risks with AOC (and we should), it follows that we should be able to take lower-level risks if she doesn’t throw her hat in the ring. What’s Your Plan B? The US Left is facing its biggest opening for growth and influence since the 1930s. Initiatives that would have been impossible a few months ago are now potentially feasible. A President AOC is now easier to imagine, but if she ultimately assesses that the risks aren’t worth the potential reward in 2028, we can’t be left flat-footed. So even if you’re not convinced by the specifics of my Plan B, I hope you can at least agree that it’d be a disaster for us not to have one — and not to start getting a Plan B into motion. Hopefully other organizers and political currents will put forward their responses and alternative ideas ASAP. The stakes are too high to just wait and see. More As always, please share this article widely. This newsletter depends on all you lovely people to get the word out. Thank you! I uploaded the full text of my Catalyst article on Milwaukee sewer socialism here (it’s updated and 3x as long as the version published earlier on this substack). If you haven’t yet, please make sure to subscribe to Catalyst here; I read every issue front to back, highly recommend. 🌹🎵 Ivan Lins (arranged by Arthur Verocai) — “General da Banda” 🌹🎵
At colleges, the AI boom means everyone wants to dabble in computer science
WCHS ABC 8 provides local news, weather forecasts, traffic updates, notices of events and items of interest in the community, sports and entertainment programming for Charleston and nearby towns and communities in the Tri-State area, including Huntington, Dunbar, Marmet, Montgomery, Nitro, South Charleston, St. Albans, Cedar Grove, Chesapeake, Clendenin, East Bank, Glasgow, Pratt, Cross Lanes, Elkview, Pinch, Sissonville, Big Chimney, Cabin Creek, Chelyan, Davis Creek, Institute, Jefferson, Loudendale, Mink Shoals, Pocatalico, Quick, Quincy, Rand, Buffalo, Eleanor, Hurricane, Nitro, Poca, Winfield, Culloden, Fraziers Bottom, Hometown, Red House, Scott Depot, Teays Valley, Danville, Madison, Hamlin, Logan, Chapmanville, Man, Delbarton, Kermit, Gilbert, Matewan, Williamson, Summersville, Richwood, Flatwoods, Gassaway, Sutton, Spencer, Ravenswood, Ripley, Mason, Point Pleasant, Ashland, Pikeville, Ironton, Portsmouth, Gallipolis, and Athens.
3 questions for the 49ers at running back
Will Kyle Shanahan trust the other running backs?
Debt Digest | Federal Debt is a Health Care Problem
Welcome David Ditch to the Debt Dispatch! We are pleased to announce a new regular contributor: David Ditch will be joining the Cato Institute as a Policy Analyst for Budget and Entitlement Policy later this week. David has more than a decade of experience in fiscal policy issues, with a particular focus on federal spending. He previously worked at the Senate Budget Committee, the Heritage Foundation, and the Economic Policy Innovation Center. David’s areas of expertise include appropriations, transportation, agriculture, federalism, grantmaking, and policy options for deficit reduction. Originally from the Rochester, N.Y. area, David has a BA in Economics and Political Science from the University of Rochester and a MA in Political Management from George Washington University. David currently lives in Arlington, VA. You may have enjoyed his earlier guest posts: CBO: New Highway Bill Has More Spending, Taxes, and Deficits Trump Administration’s Proposed Changes to Federal Grants Highlight Problems of Big Government Here are this week’s reading links and fiscal facts: The federal debt is largely a health care problem. In a new report, the Congressional Budget Office and Joint Committee on Taxation find that “In 2026, federal subsidies for health insurance, net of related payments to the government, are projected to equal $2.4 trillion, or 7.4 percent of gross domestic product (GDP). In CBO and JCT’s projections, those subsidies grow by 65 percent, reaching $3.9 trillion, or 8.4 percent of GDP, in 2036. Subsidies for Medicare contribute most to that overall growth, increasing by $900 billion. Over the entire 2026–2036 period, federal subsidies for health insurance total $33.6 trillion.” Cato’s Michael Cannon emphasizes, “The long-term federal debt problem is a health care problem. […] Only two categories of federal outlays will grow faster than gross domestic product (GDP): health care subsidies and interest payments on the debt. The former is, therefore, the primary driver of the latter.” The bond market fears deficits, not the loss of tariff revenue. Responding to a New York Times essay claiming tariff revenue has grown too important for a future administration to unwind, Cato’s Kyle Handley argues: “Bond investors are not attached to customs duties as a line item revenue source. They care about the government’s overall fiscal position.” He continues, “tariff revenue is a side hustle. And the Trump administration has already promised to dole out the funds through schemes like tariff dividend rebates, farm subsidies, and pay-fors on tax cuts or other spending.” Furthermore, “tariff revenue is simply not large enough to transform the government’s fiscal trajectory.” Take net interest for example: it “reached $970 billion in fiscal year 2025, absorbing 18.5 percent of federal receipts. Customs duties accounted for only 3.7 percent of receipts—and that was before refunds (see Figure 2).” Handley concludes, “The real bond-market concern is a large and growing interest bill, persistent budget deficits, and a political system unwilling to bring spending and revenue into alignment.” Medicare’s spending growth is driven by more volume and utilization. A Congressional Research Service report finds that Medicare spending “grew at an average annual rate of 7.3%” from 1985 through 2025, and the trustees project health care expenditures will keep rising “faster than gross domestic product (GDP) in most future years.” Citing CBO, the report attributes Medicare’s projected 2026–2036 spending growth to “23% from higher enrollment, 31% from inflation, and 47% from the growth of inflation-adjusted spending per beneficiary. In other words**, the largest single driver of Medicare spending growth during the next decade is expected to be higher volume and intensity of health care services.”** Boccia and Thakur explain: “as the economy grows, Medicare spending tends to grow at least as fast—and often faster—because the program automatically pays the bill for more and more healthcare consumption by seniors, even as prices rise.” The Fed has little control over market interest rates. Cato’s Jai Kedia documents that the Fed has held its rate target steady since December, yet “nearly every rate Americans actually borrow at has climbed over the same stretch.” Kedia continues, “The Fed did nothing, and the cost of credit went up anyway. […] Markets spent these months repricing macroeconomic events such as sticky core inflation, a volatile energy market driven by the conflict in the Middle East, and global trade disrupted by tariffs, among others. None of that required a policy change to show up in borrowing costs because markets, not the FOMC, set prices.” He concludes, “Accurately priced borrowing rates will come from credible disinflation and disciplined budgets and from a Fed content to follow the economy rather than pretend it leads it.” Nearly half of US farm income comes from taxpayers. Former Reagan OMB director David Stockman notes that “in the most recently completed full year (FY 2025) farmer incomes in the US totaled $97.8 billion, but fully 42.7% or $41.8 billion of that amount came from taxpayers, not the marketplace. Nor is this some kind of one-year aberration. If we look at the most recent decade as a whole, total farm income posted at nearly $708 billion, but, as indicated, fully $322 billion or 45% of this came compliments of US taxpayers.” Cato’s Chris Edwards explains why so little of that income is market-earned: “Farmers are businesspeople, but the government shields them from just about every type of weather and market risk. Furthermore, just about every part of the agricultural industry is subsidized, including insurance, loans, marketing, research, export sales, and land improvements.” The Debt Dispatch is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe
Fast Track Provides Shareholder Update on IP-Led Growth Strategy and Sony Music Entertainment Malaysia Partnerships Following LAUNCHPAD Media Launch
SINGAPORE, Aug. 03, 2026 (GLOBE NEWSWIRE) -- FAST TRACK GROUP (NASDAQ: FTRK) (
The Sports Report: Dodgers have Skubal, but are swept by Red Sox
The Dodgers finalize their trade for pitcher Tarik Skubal, then get swept by Red Sox after bad start by Emmet Sheehan.
MLB Predictions and Moneyline Picks for Monday, August 3
Moneyline leans and insights for Monday, August 3 from Colby Marchio. Check out the teams he's backing this evening!
The MLB trade deadline is here, plus Rodgers talks reconciliation
The Pulse Newsletter 📣 | This is The Athletic’s daily sports newsletter. Sign up here to receive The Pulse directly in your inbox. Good morning! It’s great to be back with you. Coming up: ⚾ MLB trade deadline latest ⚽ Soccer mess deepens 🗣️ Rodgers speaks out Just 12 hours separate the time this email landed in your inbox and MLB’s trade deadline at 6 p.m. ET today. It’s easy to wonder if there will be any intrigue at all, with the market’s biggest name already settling into his new Dodger home. Let’s catch up on yesterday’s deals before we get to today:...
Cubs Interested in Multiple Starters Following Kevin Gausman Trade: Report
After acquiring SP Kevin Gausman, the Chicago Cubs aren't done making trades ahead of the MLB's Aug.3 deadline. The post Cubs Interested in Multiple Starters Following Kevin Gausman Trade: Report appeared first on HEAVY.
Giants vs Padres Highlights ⚾️ MLB on FOX
Watch the best highlights between the San Francisco Giants and the San Diego Padres.
Twins vs Mariners Highlights ⚾️ MLB on FOX
Watch the best highlights between the Minnesota Twins and the Seattle Mariners.
Phillies vs Orioles Highlights ⚾️ MLB on FOX
Watch the best highlights between the Philadelphia Phillies and the Baltimore Orioles.
Yankees vs Cubs Highlights ⚾️ MLB on FOX
Watch the best highlights between the New York Yankees and the Chicago Cubs.
Blue Jays Announce Trade Amid Kevin Gausman Rumors
The Toronto Blue Jays made a trade for a recently designated for assignment pitcher. This has possible implications for Kevin Gausman at the MLB trade deadline.
Pirates vs Reds Highlights ⚾️ MLB on FOX
Watch the best highlights between the Pittsburgh Pirates and the Cincinnati Reds.
Marlins vs Mets Highlights ⚾️ MLB on FOX
Watch the best highlights between the Miami Marlins and the New York Mets.
Let’s do science: Share your wild turkey sightings
MAINE—All good wildlife management starts with science, and all good science starts with data. That’s where you come in. Maine’s Wild Turkey August Production Survey invites community scientists to play a direct role in monitoring our state’s wild turkey population. Whether you enjoy watching wildlife from your window, spend time hiking, hunting, or exploring the outdoors, or just need an excuse to get outside, you can help. Each summer, Maine’s wild turkey hens are busy raising the next generation of birds. By reporting your sightings and observations, you’ll help our biologists monitor annual reproduction rates, track population trends, and make informed management decisions that support healthy, sustainable turkey populations for generations to come. The information collected helps ensure there are abundant opportunities for both wildlife watchers and hunters to enjoy Maine’s wild turkeys. It’s easy to participate! Whenever you see wild turkeys anywhere in Maine during August, simply report: Date and location of your observation Number of adult females (hens) Number of adult males (gobblers) Number of poults (young turkeys) Estimated poult size relative to the adult hens Every observation counts, even if you don’t see poults. Together, these reports provide a clearer picture of turkey productivity across the state and are an important part of Maine’s wildlife management. Ready to help? Report your turkey sightings online using the Wild Turkey August Production Survey. Submit an Observation Subscribe Share Leave a comment
GameThread: Detroit Tigers vs. Athletics, 4:05 p.m.
Detroit Tigers vs. Athletics Time/Place: 4:05 p.m., Sutter Health ParkSB Nation Site: Athletics NationMedia: Detroit SportsNet, MLB.TV, Tigers Radio Network
N.J. county fair guide 2026: 5 fairs happening this week across the Garden State
All nine county fairs are mapped out by date and location. Check out all the details.
How to live stream Yankees vs Cubs: MLB, TV channel
The New York Yankees (62-49) and Chicago Cubs (63-48) decide their three-game series on Sunday after the Cubs evened things up with a win on Saturday night at Wrigley Field. How to Watch New York Yankees vs Chicago Cubs Pete…
2026 Mets Draft: Post-Draft Thoughts
A few thoughts with the 2026 MLB Draft now firmly in the rearview mirror.
With 1 more loss, Rangers could be open for business ahead of MLB trade deadline
The Rangers' Sunday game against the Astros is about as big as they come on deadline eve.
Health department temporarily closes restaurant, fire destroys 12 apartments and more Flint-area news
Learn more about these stories and other Flint-area news with these local headlines from the past week.
They made a living on Russia’s Amazon. Ukrainian attacks have sent it up in flames.
Attacks have hit warehouses belonging to the company almost daily — a new chapter in Kyiv’s campaign of long-range drone strikes designed to inflict maximum pain on the Kremlin.
Rays Reacts Results: Winning the AL East
The trade deadline approaches tomorrow afternoon, and we’ve already seen one major domino fall in the last few hours, as the Dodgers have miraculously scooped up Tarik Skubal for just OF Zyhir Hope (ranked in the 25-50 range on MLB top prospect lists) and two throw-ins (injured RHP River Ryan and wonky RHP Brady Smith). […]
Yankees' Spencer Jones is Making an 'Untouchable' Case
New York Yankees outfielder Spencer Jones is flashing significant potential before the MLB trade deadline.
Gasperini appreciates Endrick, Roma in contact with Brazilian
Roma continues to eye Endrick as an attacking target. The Brazilian is on the Giallorossi’s shortlist, much more so than Mastantuono. Gasperini is reportedly firmly convinced he can transform him in...
Maine’s Democratic Senate candidate touts his rural appeal. His hometown has mixed feelings.
In Allagash, a hamlet of some 200 people near Canada, residents are sharply divided over Troy Jackson.
From occupied Crimea to Oxfordshire: the Kremlin links to new £600m UK theme park
Exclusive: Puy du Fou worked with under-sanctions oligarch on plans for Crimea resort longer than disclosed, and later courted Iran and China
Tigers vs Athletics Highlights ⚾️ MLB on FOX
Watch the best highlights between the Detroit Tigers and the Athletics.
Brewers vs Angels Highlights ⚾️ MLB on FOX
Watch the best highlights between the Milwaukee Brewers and the Los Angeles Angels of Anaheim.
Giants vs Padres Highlights ⚾️ MLB on FOX
Watch the best highlights between the San Francisco Giants and the San Diego Padres.
Red Sox vs Dodgers Highlights ⚾️ MLB on FOX
Watch the best highlights between the Boston Red Sox and the Los Angeles Dodgers.
Recap: Ten-man Sporting KC falls 2-0 to Houston Dynamo
A short-handed Sporting Kansas City (4-12-2, 14 pts.) fell to a 2-0 defeat against the Houston Dynamo (9-6-2, 29 pts.) at Sporting Park on Saturday night. Lasse Berg Johnsen was shown a red card just before halftime before the Dynamo grabbed a pair of goals in the second half to
Royals vs Rockies Highlights ⚾️ MLB on FOX
Watch the best highlights between the Kansas City Royals and the Colorado Rockies.
Pirates vs Reds Highlights ⚾️ MLB on FOX
Watch the best highlights between the Pittsburgh Pirates and the Cincinnati Reds.
Diamondbacks vs Guardians Highlights ⚾️ MLB on FOX
Watch the best highlights between the Arizona Diamondbacks and the Cleveland Guardians.
Yoshinobu Yamamoto goes deep, Dodgers can’t support him
Yoshinobu Yamamoto pitched eight strong innings, but the Dodgers offense didn’t support him, falling to the Boston Red Sox 3-2 on Saturday night at Dodger Stadium. Yamamoto, who leads MLB averaging 6.68 innings per start, completed eight innings for the fourth time this season, tying Marlins ace Sandy Alcantara for the major league lead. Yamamoto […]
Rangers vs Astros Highlights ⚾️ MLB on FOX
Check out the best moments from the matchup between the Texas Rangers and the Houston Astros.
Phillies vs Orioles Highlights ⚾️ MLB on FOX
Watch the best highlights between the Philadelphia Phillies and the Baltimore Orioles.
Yankees vs Cubs Highlights ⚾️ MLB on FOX
Check out the best moments in the matchup between the New York Yankees and the Chicago Cubs.
Chicago Cubs Announce Seiya Suzuki Decision Before Yankees Game
The Chicago Cubs are currently taking on the New York Yankees in an interleague showdown between two of MLB’s most historic franchises. Chicago dropped the first game of its series with the Yankees, and on Saturday, David Peterson (6-7, 5.80 ERA, 77 SO) will get the nod against the Yankees’ starter Max Fried. In the […] The post Chicago Cubs Announce Seiya Suzuki Decision Before Yankees Game appeared first on HEAVY.
Twins vs Mariners Highlights ⚾️ MLB on FOX
Watch the best highlights between the Minnesota Twins and the Seattle Mariners.
Atlanta Braves Predicted to Trade for Angels’ Jose Soriano
The Atlanta Braves could be on the cusp of acquiring a front-line starter to pair with dominant ace Chris Sale. The MLB trade deadline is just over 48 hours away, and the Braves are featured in several speculative trade rumors. One recent one, per the New York Post’s Jon Heyman, indicates the Braves have interest […] The post Atlanta Braves Predicted to Trade for Angels’ Jose Soriano appeared first on HEAVY.
Cardinals vs Blue Jays Highlights ⚾️ MLB on FOX
Check out the highlights in the matchup between the St. Louis Cardinals and the Toronto Blue Jays.
Source: Former MLB executive Tim Brosnan to head Big East
The Big East is expected to hire former MLB executive Tim Brosnan as the league's next commissioner, sources told ESPN.
Grading MLB Trade Deadline Deals: Will Doval Improve Pirates Bullpen?
We're grading the deals ahead of Monday's MLB trade deadline.
MLB insider Jon Morosi gives Tarik Skubal trade sweepstakes update
Will any MLB team meet the Tigers demands?
In deal for reliable arm Dean Kremer, Twins, Orioles both get what they need: MLB Trade Grades
Dean Kremer has had an awful season, but a long track record says he should bounce back to being reliably average.
Player status report, presented by Orlando Health: Orlando City SC at Red Bull New York
Here is the Player Status Report, presented by Orlando Health, for Saturday's away match at Red Bull New York
MLB rumors: Bombshell Cubs-Mariners trade floated before deadline
The Cubs' relentless hunt for a starting pitcher on the trade market could lead them straight to a blockbuster deal with the Mariners.
2026 MLB Trade Deadline: Open Thread
2026 MLB Trade Deadline: updates and discussion
2026 MLB Odds: Dodgers Become Major Liability Amid Skubal Trade Talks
The Dodgers, as well as a few surprise contenders, have become major sportsbook liabilities ahead of the trade deadline. Patrick Everson breaks it down.
Player Availability Report: #SKCvHOU
Player Availability Report is SportingKC.com’s look at the latest status updates around the team ahead of upcoming matches and is presented by Saint Luke’s. All details listed are from the league’s official Player Status Report that is submitted the day prior to the match. Sporting Kansas City returns home this